| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/24/1998 | US5840900 High molecular weight polymer-based prodrugs |
| 11/24/1998 | US5840883 Dextrin ester of fatty acids and use thereof |
| 11/24/1998 | US5840860 Delivering fatty acid to colon by linking fatty acid to a carbohydrate carrier |
| 11/24/1998 | US5840854 Monoclonal antibody BR110 and uses thereof |
| 11/24/1998 | US5840837 Coupling protected amino acids, optionally on a resin, deprotecting and purifying polypeptide product |
| 11/24/1998 | US5840769 Comprising powdered cellulose, soluble polyvinylpyrrolidone, crosslinked insoluble polyvinylpyrrolidone in specified amounts |
| 11/24/1998 | US5840768 MCC: alginate pharmaceutical suspensions |
| 11/24/1998 | US5840757 Lipid emulsion intended for parenteral or enteral feeding |
| 11/24/1998 | US5840754 Dosage form comprising oxybutynin |
| 11/24/1998 | US5840744 Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
| 11/24/1998 | US5840737 Carrier of bicarbonate of 1a metal; single dose |
| 11/24/1998 | US5840733 Argatroban derivatives which can be covalently linked to various blood components |
| 11/24/1998 | US5840714 Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, pharmaceutical preparations containing said inclusion complexes and methods for using same |
| 11/24/1998 | US5840713 Therapy for tissue membrane insufficiency |
| 11/24/1998 | US5840710 Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules |
| 11/24/1998 | US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component |
| 11/24/1998 | US5840701 Antiischemic agents and macomolecules |
| 11/24/1998 | US5840685 Intravaginal delivery of biologically active polypeptides |
| 11/24/1998 | US5840674 Delivering active materials to mammalian cells |
| 11/24/1998 | US5840588 Binding hapten to erythrocyte or latex particles; mixing sample with antibody against hapten, combining antibody with bound hapten; agglutination occurs only when lack of hapten in sample; simplicity, high speed, specificity |
| 11/24/1998 | US5840522 Recombinant lectins |
| 11/24/1998 | US5840387 Sulfonated multiblock copolymer and uses therefor |
| 11/24/1998 | US5840341 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential |
| 11/24/1998 | US5840340 Oligopeptides with fragrance, cosmetics and dye |
| 11/24/1998 | US5840339 Blood cholesterol reducing pharmaceutical composition |
| 11/24/1998 | US5840337 Gelling liquid polyethylene glycol at room temperature with calcium acetate |
| 11/24/1998 | US5840330 Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained |
| 11/24/1998 | US5840317 Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen |
| 11/24/1998 | US5840307 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation |
| 11/24/1998 | US5840294 Method for treating amyloidosis |
| 11/24/1998 | US5840293 Topical composition comprising carrier with dispersed noncollapsible crosslinked polymeric beads having network of internal pores containing active substance and exterior surface charge which promotes adhesion to keratinic materials |
| 11/24/1998 | US5840283 Composition and method for treating diseased nails |
| 11/24/1998 | US5840275 Ultrasonic contrast agent with polymeric gas or air filled microballoons |
| 11/24/1998 | US5840252 Basifying liquid product, adding carbon dioxide or carbon dioxide-forming compound to solution, storing in gas permeable container, allowing ph to increase with release of carbon dioxide; stable dialysis solutions |
| 11/24/1998 | US5840213 Uses of heptafluoropropane |
| 11/19/1998 | WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
| 11/19/1998 | WO1998051812A2 Polyhydroxyalkanoates for in vivo applications |
| 11/19/1998 | WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 11/19/1998 | WO1998051784A1 Modiified arginine deiminase |
| 11/19/1998 | WO1998051685A1 Method of manufacturing sertindole |
| 11/19/1998 | WO1998051408A1 Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties |
| 11/19/1998 | WO1998051349A1 Conjugate comprising a folic acid antagonist and a carrier |
| 11/19/1998 | WO1998051348A2 Sustained-release delayed gels |
| 11/19/1998 | WO1998051347A1 Biofunctional polymers prepared in supercritical fluid |
| 11/19/1998 | WO1998051342A1 Substrates materials with bound cytokine-stimulating polysaccharides or bacterial nucleic acids |
| 11/19/1998 | WO1998051341A1 ANTIGEN-mPEG CONJUGATES SUPPRESS HUMORAL AND CELL MEDIATED IMMUNE RESPONSES |
| 11/19/1998 | WO1998051339A1 Multivalent vaccine composition with mixed carrier |
| 11/19/1998 | WO1998051336A1 Targeted delivery to t lymphocytes |
| 11/19/1998 | WO1998051328A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets |
| 11/19/1998 | WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 11/19/1998 | WO1998051299A1 Patches containing isosorbide nitrate |
| 11/19/1998 | WO1998051284A1 Novel acoustically active drug delivery systems |
| 11/19/1998 | WO1998051282A1 Solid porous matrices and methods of making and using the same |
| 11/19/1998 | WO1998051281A1 Aqueous suspension preparations with excellent redispersibility |
| 11/19/1998 | WO1998051280A1 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs |
| 11/19/1998 | WO1998051278A2 High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 11/19/1998 | WO1998051244A1 Intrauterine chemical necrosing method, composition, and apparatus |
| 11/19/1998 | WO1998051217A1 Vaccine against lipopolysaccharide core |
| 11/19/1998 | WO1998036740A3 Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties |
| 11/19/1998 | WO1998035694A3 A pharmaceutical composition for treating hepatitis b virus (hbv) infection |
| 11/19/1998 | DE3845000C2 Compsn. contg. somatostatin analogues for treating breast cancer |
| 11/19/1998 | DE19720083A1 Pharmaceutical composition comprises cotton wool seed oil |
| 11/19/1998 | CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 11/19/1998 | CA2290071A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
| 11/19/1998 | CA2289760A1 Vaccine against lipopolysaccharide core |
| 11/19/1998 | CA2289618A1 Aqueous suspension preparations with excellent redispersibility |
| 11/19/1998 | CA2289448A1 Conjugate comprising a folic acid antagonist and a carrier |
| 11/19/1998 | CA2286875A1 Chemical compounds |
| 11/18/1998 | EP0878201A1 Preventives and remedies for thrombocytopenia |
| 11/18/1998 | EP0878191A2 Stable aqueous solution containing selegiline and device for its administration |
| 11/18/1998 | EP0877816A1 Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines |
| 11/18/1998 | EP0877629A2 Lipophilic peptides for macromolecule delivery |
| 11/18/1998 | EP0877628A2 Buffer systems for use in stabilizing pharmaceutical preparations |
| 11/18/1998 | EP0877622A1 Method of inactivation of ras subfamily proteins and agents therefor |
| 11/18/1998 | EP0877605A2 Solid instant-release forms of administration and process for producing the same |
| 11/18/1998 | EP0877603A2 Methods and compositions for enhancing the bioadhesive properties of polymers |
| 11/18/1998 | EP0877600A1 Preservative systems for pharmaceutical compositions containing cyclodextrins |
| 11/18/1998 | EP0877598A1 Anthelmintic paste |
| 11/18/1998 | EP0877562A1 Water dispersible compositions containing natural hydrophilic, water-insoluble pigments, methods of preparing same and their use |
| 11/18/1998 | EP0749304B1 Slow-release tablet containing diclofenac-na |
| 11/18/1998 | EP0746310B1 Controlled release composition |
| 11/18/1998 | EP0711142B1 Use of cross-linked copolymers of monoethylenically unsaturated carboxylic acids as stabilizers in oil-in-water emulsions |
| 11/18/1998 | EP0697821B1 Cholesterol lowering drink mix compositions |
| 11/18/1998 | CN1199339A Aqueous eye drops contg. apafant as principal agent |
| 11/18/1998 | CN1199335A Pharmaceutical preparation contg. nimesulide for topical use |
| 11/18/1998 | CN1199334A Long-lasting composition for rectal administration |
| 11/17/1998 | US5837845 Dna encoded human monoclonal antibodies for binding antigens of stomach cancer cells |
| 11/17/1998 | US5837814 Drug delivery; medical diagnosis; separations; protein fusion products |
| 11/17/1998 | US5837808 Anticoagulants |
| 11/17/1998 | US5837759 Stabilizer mixture of chroman derivatives and inert organic solvents, and microcapsules containing this stabilizer mixture |
| 11/17/1998 | US5837747 Lipids, polycations or polysaccharides with double or triple bonds for crosslinking for cells |
| 11/17/1998 | US5837735 Nimesulide as antiinflammatory agents |
| 11/17/1998 | US5837690 Derivatives of triterpenoid acids and uses thereof. |
| 11/17/1998 | US5837673 Camptothecin derivatives |
| 11/17/1998 | US5837533 Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| 11/17/1998 | US5837491 Polynucleotides encoding gelonin sequences |
| 11/17/1998 | US5837291 Enteric preparation coated with a non-solvent enteric coating agent using a liquid plasticizer |
| 11/17/1998 | US5837289 Transdermal delivery of medications using a combination of penetration enhancers |
| 11/17/1998 | US5837286 Taste masking for unplatable formulations |
| 11/17/1998 | US5837283 Cationic lipid compositions targeting angiogenic endothelial cells |